Anti-Fc?RIIB mAb suppresses murine IgG-dependent anaphylaxis by Fc domain targeting of Fc?RIII - 05/04/18
Abstract |
Background |
The inhibitory receptor FcγRIIB is expressed on human and murine bone marrow–derived cells and limits inflammation by suppressing signaling through stimulatory receptors.
Objective |
We sought to evaluate the effects of K9.361, a mouse IgG2a alloantibody to mouse FcγRIIB, on murine anaphylaxis.
Methods |
Wild-type and FcγR-deficient mice were used to study anaphylaxis, which was induced by injection of 2.4G2 (rat IgG2b mAb that binds both FcγRIIB and the stimulatory receptor FcγRIII), by actively immunizing IgE-deficient mice and then challenging with the immunizing antigen, and by passive immunization with IgG or IgE anti–2,4,6-trinitrophenyl mAb, followed by injection of 2,4,6-trinitrophenyl–ovalbumin. Pretreatment with K9.361 was assessed for its ability to influence anaphylaxis.
Results |
Unexpectedly, K9.361 injection induced mild anaphylaxis, which was both FcγRIIB and FcγRIII dependent and greatly enhanced by β-adrenergic blockade. K9.361 injection also decreased expression of stimulatory Fcγ receptors, especially FcγRIII, and strongly suppressed IgG-mediated anaphylaxis without strongly affecting IgE-mediated anaphylaxis. The F(ab′)2 fragment of K9.361 did not induce anaphylaxis, even after β-adrenergic blockade, and did not deplete FcγRIII or suppress IgG-mediated anaphylaxis but prevented intact K9.361-induced anaphylaxis without diminishing intact K9.36 suppression of IgG-mediated anaphylaxis.
Conclusion |
Cross-linking FcγRIIB to stimulatory FcγRs through the Fc domains of an anti-FcγRIIB mAb induces and then suppresses IgG-mediated anaphylaxis without affecting IgE-mediated anaphylaxis. Because IgG- and IgE-mediated anaphylaxis can be mediated by the same cell types, this suggests that desensitization acts at the receptor rather than cellular level. Sequential treatment with the F(ab′)2 fragment of anti-FcγRIIB mAb followed by intact anti-FcγRIIB safely prevents IgG-mediated anaphylaxis.
Le texte complet de cet article est disponible en PDF.Key words : Fc receptors, anaphylaxis, mouse, signaling, IgG, IgE
Abbreviations used : EW, FcγR, FcRγ, FSC, ITAM, ITIM, MFI, OVA, SSC, TNP, WT
Plan
Supported by National Institutes of Health (NIH) grant R01 AI113162, a Merit Award to F.D.F. from the US Department of Veterans Affairs, the NIH-supported Immunology/Allergy Fellowship Training Program (T32AI060515-11), and the Department of Internal Medicine, University of Cincinnati Medical Center. |
|
Disclosure of potential conflict of interest: C. D. Clay receives grant support from the National Institutes of Health (NIH). F. D. Finkelman serves as a consultant for Vedanta Bioscience, is an employee of the University of Cincinnati, receives grant support from the NIH and Food Allergy Research & Education (FARE), and has 3 patents pending with the University of Cincinnati. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 141 - N° 4
P. 1373 - avril 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?